Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) Shares Outstanding (Diluted Average) (2021 - 2026)

Trulieve Cannabis has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $191.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 0.7% year-over-year to $191.3 million; the TTM value through Dec 2025 reached $191.3 million, up 0.7%, while the annual FY2025 figure was $191.3 million, 0.7% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $191.3 million at Trulieve Cannabis, roughly flat from $191.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $191.3 million in Q4 2025 and troughed at $146.8 million in Q4 2021.
  • A 5-year average of $186.9 million and a median of $189.5 million in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 28.1% in 2022 and later rose 0.17% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $146.8 million in 2021, then rose by 28.1% to $188.0 million in 2022, then increased by 0.52% to $189.0 million in 2023, then rose by 0.54% to $190.0 million in 2024, then increased by 0.7% to $191.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for TCNNF at $191.3 million in Q4 2025, $191.2 million in Q3 2025, and $191.2 million in Q2 2025.